| Members |
targetComponentId |
| Local fasciocutaneous flap NOS |
Local fasciocutaneous flap |
| Local fasciocutaneous flap to head or neck NEC |
Local fasciocutaneous flap |
| Local flap of skin to head or neck NEC |
Reconstruction with local flap |
| Local flap reconstruction by V-Y advancement - action |
Local flap reconstruction by advancement - action (qualifier value) |
| Local pedicle V-Y flap reconstruction - action |
Local flap reconstruction - action |
| Local pedicle flap reconstruction - action |
Local flap reconstruction - action |
| Local pedicle island flap reconstruction - action |
Local flap reconstruction - action |
| Local sensory skin flap NEC |
Local sensory skin flap (procedure) |
| Local subcutaneous pedicle flap, myocutaneous NEC |
Reconstruction using local subcutaneous pedicle myocutaneous flap |
| Local subcutaneous pedicle island flap to head or neck NEC |
Reconstruction using local subcutaneous pedicle island flap |
| Local subcutaneous pedicle island flap, axial pattern NEC |
Reconstruction using local axial pattern subcutaneous pedicle island flap |
| Local subcutaneous pedicle island flap, axial pattern, to head or neck |
Reconstruction of skin using local subcutaneous pedicle island axial pattern skin flap (procedure) |
| Local subcutaneous pedicle island flap, fasciocutaneous NEC |
Reconstruction using local subcutaneous pedicle fasciocutaneous flap |
| Local subcutaneous pedicle island flap, random pattern NEC |
Reconstruction using local subcutaneous pedicle island random pattern flap (procedure) |
| Local subcutaneous pedicle island flap, random pattern, to head or neck |
Reconstruction of skin using local subcutaneous pedicle island random pattern skin flap (procedure) |
| Local subcutaneous pedicle skin flap NOS |
Reconstruction of skin using local subcutaneous pedicle skin flap (procedure) |
| Local transposition flap, axial pattern NEC |
Local transposition flap - axial pattern |
| Local transposition flap, random pattern NEC |
Local transposition flap - random pattern |
| Localization-related epilepsy |
Partial seizure |
| Localized adult periodontitis |
Localized chronic periodontitis |
| Localized dermatitis caused by drug taken internally |
Localized dermatitis caused by substance taken via oral route (disorder) |
| Locked twins obstructing labor |
Interlocked twins |
| Lomefloxacin 0.3% eye drops |
Lomefloxacin 3 mg/mL eye solution |
| Long atonic seizure |
Atonic epileptic seizure (finding) |
| Long-acting thyroid stimulator |
Thyroid stimulating immunoglobulins |
| Loperamide 2mg oral lyophilisate tablet |
Loperamide hydrochloride 2 mg oral tablet |
| Loperamide hydrochloride 1mg/5mL conventional release oral syrup |
Product containing precisely loperamide hydrochloride 200 microgram/1 milliliter conventional release oral solution (clinical drug) |
| Loperamide hydrochloride 1mg/5mL sugar free syrup |
Product containing precisely loperamide hydrochloride 200 microgram/1 milliliter conventional release oral solution (clinical drug) |
| Loperamide hydrochloride 2mg orodispersible tablet |
Loperamide hydrochloride 2 mg oral tablet |
| Loperamide hydrochloride+simethicone |
Product containing loperamide and simeticone (medicinal product) |
| Lophortyx gambelii |
Callipepla gambelii (organism) |
| Loracarbef 100mg/5mL oral suspension |
Product containing precisely loracarbef 20 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Loracarbef 100mg/5mL suspension |
Product containing precisely loracarbef 20 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Loracarbef 200mg/5mL oral suspension |
Loracarbef 40 mg/mL oral suspension |
| Loracarbef 200mg/5mL suspension |
Loracarbef 40 mg/mL oral suspension |
| Loracarbef, anhydrous 100mg/5mL powder |
Product containing precisely loracarbef 20 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Loracarbef, anhydrous 200mg/5 mL powder |
Loracarbef 40 mg/mL oral suspension |
| Loratadine 10mg/10mL syrup |
Loratadine 1 mg/mL oral solution |
| Loratadine+pseudoephedrine sulfate 5mg/120mg m/r tablet |
Loratadine and pseudoephedrine only product in oral dose form |
| Loratadine+pseudoephedrine sulfate 5mg/120mg prolonged-release oral tablet |
Loratadine and pseudoephedrine only product in oral dose form |
| Lordosis in hip disease |
Lordosis deformity of spine due to disorder of hip region |
| Lordosis in skeletal dysplasia |
Lordosis deformity of spine due to congenital skeletal dysplasia |
| Lovastatin 10mg m/r tablet |
Product containing only lovastatin in oral dose form (medicinal product form) |
| Lovastatin 10mg prolonged-release oral tablet |
Product containing only lovastatin in oral dose form (medicinal product form) |
| Lovastatin 20mg m/r tablet |
Product containing only lovastatin in oral dose form (medicinal product form) |
| Lovastatin 20mg prolonged-release oral tablet |
Product containing only lovastatin in oral dose form (medicinal product form) |
| Lovastatin 40mg m/r tablet |
Product containing only lovastatin in oral dose form (medicinal product form) |
| Lovastatin 40mg prolonged-release oral tablet |
Product containing only lovastatin in oral dose form (medicinal product form) |
| Lovastatin 60mg m/r tablet |
Product containing only lovastatin in oral dose form (medicinal product form) |
| Lovastatin 60mg prolonged-release oral tablet |
Product containing only lovastatin in oral dose form (medicinal product form) |
| Low cervical cesarean section |
Lower uterine segment caesarean section |
| Césarienne cervicale basse |
Lower uterine segment caesarean section |
| Low pressure hydrocephalus |
Normal pressure hydrocephalus |
| Lower leg flap |
Flap (substance) |
| Lower leg random pattern flap |
Random pattern flap |
| Lower limb flap |
Flap (substance) |
| Lower uterine segment cesarean delivery NEC |
Lower uterine segment caesarean section |
| Lubricant substance |
Automotive lubricant |
| huile lubrifiante |
Automotive lubricating oil (substance) |
| Lucilia sericata |
Phaenicia sericata |
| Lumbar discography |
Discography with injection of contrast into intervertebral disc of lumbar spine (procedure) |
| Lumbar somatic dysfunction |
Somatic dysfunction of lumbar region (finding) |
| Lumbar spine DXA scan |
Dual energy X-ray absorptiometry of lumbar spine (procedure) |
| Lumbar spine DXA scan |
Dual energy X-ray absorptiometry of lumbar spine (procedure) |
| Lumbar spine DXA scan T score |
Dual energy X-ray photon absorptiometry lumbar spine scan T score (observable entity) |
| Lumbar spine DXA scan T score |
Dual energy X-ray photon absorptiometry lumbar spine scan T score (observable entity) |
| Lumbar spine DXA scan Z score |
Dual energy X-ray photon absorptiometry lumbar spine scan Z score (observable entity) |
| Lumbar spine DXA scan Z score |
Dual energy X-ray photon absorptiometry lumbar spine scan Z score (observable entity) |
| Lumbar spine dual energy X-ray absorptiometry scan (procedure) |
Dual energy X-ray absorptiometry of lumbar spine (procedure) |
| Lumbar spine dual energy X-ray photon absorptiometry scan T score |
Dual energy X-ray photon absorptiometry lumbar spine scan T score (observable entity) |
| Lumbar spine dual energy X-ray photon absorptiometry scan Z score |
Dual energy X-ray photon absorptiometry lumbar spine scan Z score (observable entity) |
| Lung TNM finding |
American Joint Committee on Cancer allowable value |
| Lupus erythematosus cell |
Lupus erythematosus cell |
| Luteinizing hormone releasing factor |
Gonadotropin releasing factor |
| Luteinizing hormone releasing factor preparation |
Product containing gonadotropin releasing factor (product) |
| Lutropin alfa 75iu injection (pdr for recon)+solvent |
Product containing precisely lutropin alfa 75 unit/1 vial powder for conventional release solution for injection (clinical drug) |
| Lutropin alfa 75iu injection (pdr for recon)+solvent |
Product containing precisely lutropin alfa 75 unit/1 vial powder for conventional release solution for injection (clinical drug) |
| Luy's nucleus (body structure) |
Structure of subthalamic nucleus of Luy (body structure) |
| goitre lymphadénoïde |
Hashimoto thyroiditis |
| Lymphadenopathy-associated virus, type II (LAV-II) |
Human immunodeficiency virus type 2 |
| Lymphangioma, no International Classification of Diseases for Oncology subtype |
Benign lymphangioma |
| Lymphatic incision NOS |
Incision of lymphatic system structure |
| Lymphatic incision NOS |
Incision of lymphatic system structure |
| Lymphocystis disease virus group |
Genus Lymphocystivirus (organism) |
| Lymphoid leukemia - category |
Lymphoid leukaemia |
| Lymphoma morphology |
Malignant lymphoma |
| Lymphoproliferative disease, no International Classification of Diseases for Oncology subtype |
Lymphoproliferation of uncertain behavior (morphologic abnormality) |
| Lymphosarcoma cell leukemia |
Lymphoid leukaemia |
| Lymphosarcoma cell leukemia |
Lymphoid leukaemia |
| Lymphosarcoma of extranodal AND/OR solid organ site |
Non-Hodgkin's lymphoma (clinical) |
| Lymphosarcoma of intra-abdominal lymph nodes |
Mixed cell type lymphosarcoma of intra-abdominal lymph nodes |
| Lymphosarcoma of intrapelvic lymph nodes |
Non-Hodgkin's lymphoma (clinical) |
| Lymphosarcoma of intrathoracic lymph nodes |
Mixed cell type lymphosarcoma of intrathoracic lymph nodes |
| Lymphosarcoma of lymph nodes of axilla AND/OR upper limb |
Non-Hodgkin's lymphoma (clinical) |
| Lymphosarcoma of lymph nodes of head, face AND/OR neck (disorder) |
Non-Hodgkin's lymphoma (clinical) |
| Lymphosarcoma of lymph nodes of inguinal region AND/OR lower limb |
Non-Hodgkin's lymphoma (clinical) |
| Lymphosarcoma of lymph nodes of multiple sites |
Malignant lymphoma of lymph nodes |
| Lymphosarcoma of spleen |
Non-Hodgkin's lymphoma (clinical) |
| Lyophilized powder for conventional release liposomal suspension for injection |
Lyophilized powder for conventional release suspension for injection (dose form) |
| allergie à la lypressine |
Allergy to antidiuretic hormone |
| Lysis of adhesions of abdomen |
Lysis of adhesions of peritoneum |
FHIR